Mufg Securities Emea PLC Bristol Myers Squibb CO Transaction History

Mufg Securities Emea PLC

$3.81 Billion
Q3 2025

A detailed history of Mufg Securities Emea PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mufg Securities Emea PLC holds 38,960 shares of BMY stock, worth $1.82 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

38,960

Previous 6,014 547.82%

Holding current value

$1.82 Million

Previous $278,000 532.01%

% of portfolio

0.05%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$43.31 - $48.98 $1.43 Million - $1.61 Million	32,946 Added 547.82%	38,960 $1.76 Million
Q2 2025 Aug 15, 2025	BUY	$44.12 - $59.6 $265,337 - $358,434	6,014 New	6,014 $278 Million
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $2.34 Million - $2.7 Million	45,001 Added 35.72%	171,000 $9.67 Million
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $5 Million - $6.52 Million	125,999 New	125,999 $6.52 Million
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $63.5 Million - $71.4 Million	-1,070,000 Closed	0 $0

Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $61.8 Million - $70 Million	1,070,000 New	1,070,000 $66.4 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $117 Million - $129 Million	-2,033,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $5.81 Million - $6.79 Million	106,000 Added 5.5%	2,033,000 $120 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $86.3 Million - $125 Million	1,860,938 Added 2816.96%	1,927,000 $107 Million
Q4 2019 Feb 11, 2020	SELL	$49.21 - $64.19 $144 Million - $187 Million	-2,919,615 Reduced 97.79%	66,062 $4.24 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $13.4 Million - $15.9 Million	-314,323 Reduced 9.52%	2,985,677 $151 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $852,242 - $942,394	-19,100 Reduced 0.58%	3,300,000 $150 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $46 Million - $54.8 Million	1,019,100 Added 44.31%	3,319,100 $158 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $8.74 Million - $11.3 Million	-179,239 Reduced 7.23%	2,300,000 $120 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $2.34 Million - $2.64 Million	42,408 Added 1.74%	2,479,239 $154 Million
Q2 2018 Aug 01, 2018	BUY	$50.53 - $62.98 $123 Million - $153 Million	2,436,831 New	2,436,831 $135 Million
Q1 2018 May 01, 2018	SELL	$59.92 - $68.98 $27 Million - $31 Million	-450,000 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$59.94 - $65.35 $27 Million - $29.4 Million	450,000	450,000 $27.6 Million

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.

Account

Mufg Securities Emea PLC Bristol Myers Squibb CO Transaction History